In a citizen petition posted by the FDA this week, Novo urged the regulator to restrict the ability of compounding pharmacies ...

Fintel reports that on January 8, 2025, UBS upgraded their outlook for Novo Nordisk A (NYSE:NVO) from Sell to Buy. Analyst ...

Fintel reports that on January 5, 2025, BNP PARIBAS EXANE upgraded their outlook for Novo Nordisk A (NYSE:NVO) from Neutral ...

A patient advocacy group has started a campaign to stop Novo Nordisk from following through ... basal insulins – used to provide a background dose of insulin – are not always suitable for ...

Greenland's strategic location also makes it valuable to the US. An existing US base, Pituffik Space Base , is key to US ...

Basal insulin therapy, currently administered either once or twice daily, is a well-established therapy for diabetes, providing a background ... as daily dosing with Novo Nordisk's Tresiba ...

US equity benchmarks were mixed on Wednesday as stronger than expected employment data raised concerns over future pace of ...

Salesforce is quietly emerging as a force in the artificial intelligence (AI) landscape, and the company's next big opportunity could be worth trillions. Palantir was the top-performing stock in ...

Although he has a long background with this strategy and the ... fueled by strong showings from top-10 holdings Alphabet, Meta, and Novo Nordisk, as well as a much-lesser-known name also in ...

Although he has a long background with this strategy and the ... fueled by strong showings from top-10 holdings Alphabet, Meta, and Novo Nordisk, as well as a much-lesser-known name also in ...

Get the latest news, views and opinions from Fidelity’s savings and investment experts on using brokerage to invest in ...